MADRIGAL PHARMACEUTICALS INC (NASDAQ:MDGL) Screens as High-Growth Momentum Stock Meeting Minervini Trend Template

Last update: Sep 24, 2025

MADRIGAL PHARMACEUTICALS INC (NASDAQ:MDGL) has recently appeared through a screening method that joins Mark Minervini's strict Trend Template with a concentration on high growth momentum. This two-part method tries to find companies that are both in strong technical uptrends and show the fundamental signs of very high growth, a pairing that has been a feature of some of the market's best performers. The method favors stocks showing solid price movement, better performance compared to the market, and improving financial numbers, trying to catch large moves during their most active periods.

Meeting the Minervini Trend Template

A key part of Mark Minervini's method is his Trend Template, a group of technical rules made to filter for stocks in a confirmed Stage 2 upward move. The template makes sure a stock is showing strength across different time periods. MADRIGAL PHARMACEUTICALS INC now meets these important technical requirements, which are necessary for confirming a lasting uptrend and steering clear of weaker, consolidating stocks.

Price Above Key Moving Averages: The stock's current price is trading well above its rising 50-day, 150-day, and 200-day simple moving averages. This arrangement points to positive momentum across short, intermediate, and long-term time frames.
Moving Average Arrangement: The 50-day SMA is above the 150-day SMA, which is above the 200-day SMA. This ordered arrangement of faster averages above slower ones is a typical sign of a sound, speeding up uptrend.
Proximity to Highs: The stock is trading within 4% of its 52-week high, showing strong momentum and a lack of selling pressure above the current price. Also, it sits more than 120% above its 52-week low, pointing to a strong recovery and trend shift.
Better Performance Compared to the Market: With a ChartMill Relative Strength rating of 94.83, MDGL is doing better than almost 95% of all stocks in the market. Minervini stresses that real market leaders must show better performance compared to the market, as they often lead the market higher.

Fundamentals Supporting High Growth Momentum

Besides a strong chart, the Minervini method needs sound fundamental foundations. The "High Growth Momentum" part of the screen concentrates on companies showing notable improvement in their business numbers. MADRIGAL PHARMACEUTICALS INC displays several convincing fundamental growth signs, which are important for drawing institutional interest and supporting more price increases.

Outstanding Revenue Improvement: The company has shown very high revenue growth, with TTM revenue increasing over 3,421% year-over-year. Recent quarterly sales growth is more than 1,353%. Such fast improvement is frequently a sign of an important market re-rating.
Solid Earnings Path: While the company is not yet profitable—typical for commercial-stage biopharmaceutical companies—it shows a quickly improving earnings picture. The EPS growth for the last quarter was 73.24% compared to the same quarter a year before.
Positive Analyst Changes: Analysts have meaningfully increased their estimates for the company's future performance. The average EPS estimate for next year has been moved up by 20.79% over the last three months, and revenue estimates have been moved up by 27.72%. Upward changes are a key sign of improving future growth expectations.
Perfect Earnings and Revenue Beats: The company has exceeded EPS estimates in each of the last four quarters, with an average beat of 32.47%. It has also exceeded revenue estimates in all four quarters, with an average beat of 31.95%. Regular positive beats build trust and momentum.

Technical Health and Setup Summary

The provided technical analysis report gives a complete view of the stock's health. MADRIGAL PHARMACEUTICALS INC receives a perfect technical rating of 10 out of 10, reflecting very good strength across all measured metrics. Both its short-term and long-term trends are rated as positive, and it shows a steady pattern of increasing prices.

Also, the stock shows a good setup with a rating of 9. The analysis notes lower volatility and a period of sideways movement near highs, indicating a possible break before a next move up. An important support area is found around $434.94, which could act as a sensible level for a stop-loss order in a planned entry strategy. For a detailed look at the technical view, you can examine the full technical analysis report for MDGL.

Finding Similar Opportunities

MADRIGAL PHARMACEUTICALS INC is a good example of the kind of opportunity that a joined trend and growth momentum method tries to find. Investors curious about screening for comparable companies that meet these strict technical and fundamental rules can investigate the High Growth Momentum + Trend Template screen on ChartMill.

Disclaimer: This article is for informational and educational purposes only and does not constitute investment advice. The analysis is based on current data and a specific methodology, but past performance is not indicative of future results. Always conduct your own due diligence and consider consulting with a qualified financial advisor before making any investment decisions.